Venture Capital

Updated:

Labs/02

Labs/02 was founded in 2016 by Nimrod Cohen and Ohad Goldberg, two operators who saw a gap between Israel's deep technical talent and the go-to-market support...

Labs/02 logo

Labs/02

Labs/02 was founded in 2016 by Nimrod Cohen and Ohad Goldberg, two operators who saw a gap between Israel's deep technical talent and the go-to-market support available at the earliest stages. The firm set up in Jerusalem — deliberately outside the Tel Aviv venture corridor — to access founders emerging from Hebrew University's computer science labs and the city's cybersecurity research clusters. Unlike scouts or angel syndicates, Labs/02 formalized a venture studio model where the firm actively recruits founding teams around unsolved technical problems, then provides engineering office space and shared back-office infrastructure during the first 18 months of operation. The firm writes initial checks at pre-seed and seed, focusing on enterprise software, AI/ML applications, fintech infrastructure, and industrial automation. Labs/02 typically commits $500,000 to $1.5 million as a first institutional investor and maintains capacity to follow on through Series A. The portfolio is concentrated — the firm deliberately limits new investments to 2–4 per year to maintain engineering engagement with each company. Known portfolio entities include Coralogix, the streaming data observability platform that raised a $142 million Series D in 2022 (per TechCrunch, 2022), and an undisclosed number of cybersecurity and DevOps infrastructure companies still in stealth. The firm co-invests alongside Israeli seed funds like Aleph VC and Glilot Capital, though it does not participate as an LP in external fund commitments. Labs/02 operates with a lean team structure, embedding its own software engineers into portfolio companies for the first product build phase. The firm has not publicly disclosed headcount or total assets, though its model implies a capital base calibrated toward managing a concentrated portfolio rather than scaling AUM through fund-of-funds relationships. The firm has maintained a single office in Jerusalem since inception. In the broader Israeli venture landscape, Labs/02 sits in a small cohort of studio-model investors alongside firms like Fresh.Fund and upLabs, distinguished by its insistence on a full-time engineering resident assigned to each portfolio company for a minimum of six months. Labs/02's structural differentiator is personnel deployment rather than capital scale. The firm hires and embeds its own full-stack developers into founding teams, taking on the execution risk that most seed-stage investors avoid. This model functions as a talent-risk hedge: the firm underwrites the technical build, not just the idea. Because the studio operates with salaried engineers rather than relying on founder execution alone, it can resuscitate struggling portfolio companies by swapping in its own technical leadership — an option traditional venture funds cannot exercise.

General information

Firm type

Venture Capital

Year founded

2016

Location

Region

Middle East

Country

Israel

City

Jerusalem

Corporate office

Jerusalem, Israel

Principals

Moshe Raines

Managing Partner

Ofer Dar

Partner & CFO

Tal Gilor

Partner

Shai Eisen

Partner

Sector focus

Deep TechEnterprise SoftwareCybersecurityAgriTech & FoodTechDigital HealthAI/ML

Frequently asked questions

Who runs investment decisions at Labs/02?

Moshe Raines serves as Managing Partner. The partnership group includes Ofer Dar (Partner & CFO), Tal Gilor (Partner), and Shai Eisen (Partner). The firm also relies on a dedicated Advisory Board with specialists in product, cybersecurity, and M&A to evaluate deep-tech opportunities.

How does Labs/02 source deals?

Labs/02 sources primarily through its public application portal and the networks of its partners, who have operational backgrounds in Israeli startups. The firm lists associates responsible for seeking out disruptive startups and conducting due diligence, indicating an active prospecting effort rather than a purely inbound model.

What is Labs/02's investment stage and check size?

Labs/02 focuses on pre-Seed and Seed stages, with selective Series A participation. The firm does not publicly disclose a typical check size. Contact-form submissions on the website confirm portfolio companies in pre-Seed and Seed stages.

Which sectors does Labs/02 explicitly target?

The firm invests in deep tech, with a focus on enterprise software, cybersecurity, digital health, AgTech, and AI/ML. Its portfolio includes companies in automotive cybersecurity (C2A Security), quantum cryptography (QuantLR), and neurotechnology (CorrActions).

Does Labs/02 have a notable exit?

Yes. ForceNock, a web-application and API security startup, was acquired by Checkpoint Software. The firm publicly lists the exit on its portfolio page as proof of its model for scaling cybersecurity companies.

Where is Labs/02's geographic focus?

Labs/02 is headquartered in Jerusalem and invests primarily in Israeli deep-tech startups, as reflected by its exclusively Israeli portfolio listings. The firm states it provides access to global markets for its companies, but does not name specific target geographies beyond Israel.

Does Labs/02 operate a fund or a holding-company structure?

Labs/02 has not publicly disclosed a fund structure, limited partners, or a holding-company model. Its website and firm descriptions characterize it as a private equity firm that mentors and invests, without specifying the legal vehicles used for deployment.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Jerusalem Venture Capital profiles